Cargando…

Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities

The δ-opioid receptor (δOR) holds great potential as a therapeutic target. Yet, clinical drug development, which has focused on δOR agonists that mimic the potent and selective tool compound SNC80 have largely failed. It has increasingly become apparent that the SNC80 scaffold carries with it potent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meqbil, Yazan J., Su, Hongyu, Cassell, Robert J., Mores, Kendall L., Gutridge, Anna M., Cummins, Benjamin R., Chen, Lan, van Rijn, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659279/ https://www.ncbi.nlm.nih.gov/pubmed/34885825 http://dx.doi.org/10.3390/molecules26237236

Ejemplares similares

Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
por: Meqbil, Yazan J., et al.
Publicado: (2022)

The Meta-Position of Phe(4) in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors
por: Cassell, Robert J., et al.
Publicado: (2019)

Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose
por: Sharifi, Farrokh, et al.
Publicado: (2021)

A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
por: Mores, Kendall L., et al.
Publicado: (2019)

G protein‐biased kratom‐alkaloids and synthetic carfentanil‐amide opioids as potential treatments for alcohol use disorder
por: Gutridge, Anna M., et al.
Publicado: (2020)

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions
por: Blaine, Arryn T., et al.
Publicado: (2022)

ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment
por: French, Alexander R., et al.
Publicado: (2023)

Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia
por: Dripps, Isaac J., et al.
Publicado: (2020)

In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists
por: Pradhan, Amynah A. A., et al.
Publicado: (2009)

Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
por: Gutridge, Anna M., et al.
Publicado: (2021)

Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain
por: Bushlin, Ittai, et al.
Publicado: (2012)

Allosteric GABA(A) Receptor Modulators—A Review on the Most Recent Heterocyclic Chemotypes and Their Synthetic Accessibility †
por: Vega Alanis, Blanca Angelica, et al.
Publicado: (2020)

Effects of delta-opioid receptor agonist pretreatment on the cardiotoxicity of bupivacaine in rats
por: Wang, Chenran, et al.
Publicado: (2022)

Oxygenated Polyketides from Plakinastrella mamillaris as a New Chemotype of PXR Agonists
por: Festa, Carmen, et al.
Publicado: (2013)

Delta opioid receptors in Nav1.8 expressing peripheral neurons partially regulate the effect of delta agonist in models of migraine and opioid-induced hyperalgesia
por: Bertels, Zachariah, et al.
Publicado: (2022)

Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
por: Pandey, Pankaj, et al.
Publicado: (2018)

Delta Opioid Receptor Agonists Ameliorate Colonic Inflammation by Modulating Immune Responses
por: Nagata, Kazuki, et al.
Publicado: (2021)

Development of a novel cell-based, In-Cell Western/ERK assay system for the high-throughput screening of agonists acting on the delta-opioid receptor
por: Asghar, Junaid, et al.
Publicado: (2022)

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries
por: Willems, Sabine, et al.
Publicado: (2022)

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
por: Tanguturi, Parthasaradhireddy, et al.
Publicado: (2021)

Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated
por: Polo, Sara, et al.
Publicado: (2019)

Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism
por: Milan-Lobo, Laura, et al.
Publicado: (2013)

Antitumor Cannabinoid Chemotypes: Structural Insights
por: Morales, Paula, et al.
Publicado: (2019)

The chemotype core collection of genus Nicotiana
por: Drapal, Margit, et al.
Publicado: (2022)

An aptamer agonist of the insulin receptor acts as a positive or negative allosteric modulator, depending on its concentration
por: Yunn, Na-Oh, et al.
Publicado: (2022)

Interaction between Mu and Delta Opioid Receptor Agonists in an Assay of Capsaicin-Induced Thermal Allodynia in Rhesus Monkeys
por: Negus, S. Stevens, et al.
Publicado: (2012)

Discovery of 7-Azanorbornane-Based Dual Agonists for the Delta and Kappa Opioid Receptors through an In Situ Screening Protocol
por: Karaki, Fumika, et al.
Publicado: (2023)

Probing the Activation Mechanisms of Agonist DPI-287 to Delta-Opioid Receptor and Novel Agonists Using Ensemble-Based Virtual Screening with Molecular Dynamics Simulations
por: Dean, Emily, et al.
Publicado: (2023)

Activation mechanism of the μ-opioid receptor by an allosteric modulator
por: Kaneko, Shun, et al.
Publicado: (2022)

Cannabidiol binding and negative allosteric modulation at the cannabinoid type 1 receptor in the presence of delta-9-tetrahydrocannabinol: An In Silico study
por: Chung, Hery, et al.
Publicado: (2019)

Chemotyping the distribution of vitamin D metabolites in human serum
por: Müller, Miriam J., et al.
Publicado: (2016)

Ultra-large library docking for discovering new chemotypes
por: Lyu, Jiankun, et al.
Publicado: (2019)

In depth investigation of the metabolism of Nectandra megapotamica chemotypes
por: Farias, Katyuce de S., et al.
Publicado: (2018)

Chemotypic Characterization and Biological Activity of Rosmarinus officinalis
por: Satyal, Prabodh, et al.
Publicado: (2017)

TRI Genotyping and Chemotyping: A Balance of Power
por: Villafana, Ria T., et al.
Publicado: (2020)

Ligand‐specific recycling profiles determine distinct potential for chronic analgesic tolerance of delta‐opioid receptor (DOPr) agonists
por: Bagheri Tudashki, Hanieh, et al.
Publicado: (2020)

Controlling Mammalian Gene Expression by Allosteric Hepatitis Delta Virus Ribozymes
por: Nomura, Yoko, et al.
Publicado: (2013)

Identification of Chemotypic Markers in Three Chemotype Categories of Cannabis Using Secondary Metabolites Profiled in Inflorescences, Leaves, Stem Bark, and Roots
por: Jin, Dan, et al.
Publicado: (2021)

Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
por: Mizrachi, Tehila, et al.
Publicado: (2021)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6jalgec7jg6r4t92trnmh4kah2